Exheus, the company located in the TecnoCampus and specialized in the analysis of gene expression through Artificial Intelligence (AI), has announced today the launch of Beyond You. This new brand, which is accompanied by a digital platform, will provide health professionals with personalized information to optimize the diagnosis and treatment of their patients.
Exheus is a spin-off of the Institut de Recerca del Hospital Sant Pau, the UPC and Summit SL incubated at Venture Builder The Collider, a pioneer in research and development of advanced genetic technology. The company participated in the StartHealth program for accelerating companies in the health field promoted by the TecnoCampus. Exheus was also the winner of the Creatic Award in its 19th edition.
With the application of artificial intelligence and data science, the company has developed a unique genetic test in the world, which makes it possible to measure the expression levels of genes associated with metabolic health, the state of the body's systems, longevity and the inflammatory state.
With the new digital transcriptomics platform based on mRNA analysis, health professionals can have control of a whole series of precision biomarkers to speed up diagnosis and monitor the treatment of their patients in a personalized way.
Over the last three years, Exheus has conducted extensive research and made significant advances in key areas such as obesity and overweight, sport, and inflammation. These investigations have allowed the company to advance in the field of personalized medicine by offering new mRNA markers on a pioneering digital platform. The platform will be accessible to any health professional who can be a key point for patient care.
As part of Exheus's strategy to promote the adoption of this technology in the health field, through the new Beyond You brand it has decided to establish strategic collaborations with medical and health professionals in the commercialization of their services.
“The change to Beyond You reflects our commitment to a collective and collaborative approach. By teaming up with healthcare professionals, we are building a strong network of shared knowledge and experience. Together, we can take advantage of our expertise in genetic analysis and monitoring of inflammation to develop more effective and personalized solutions”, highlights its CSO, Dr. José Manuel Soria.
This new strategic approach aims to provide users with a comprehensive view of how their genes are being activated while helping healthcare professionals make informed and personalized decisions in the field of disease treatment and prevention. .
Beyond You wants to offer its users a deep understanding of the genetic factors that influence obesity and overweight, the optimization of sports performance and the management of inflammation, among other aspects relevant to health and well-being.
Exheus technology was born more than 15 years ago in the laboratory. Soria, together with Dr. Alexandre Perera, validated the algorithms both in sports competitions such as La Marató de Barcelona and even in the Everest base camp. Studies published in prestigious scientific journals such as Science Journals and PlosOne have derived from this knowledge.
Currently, under the Beyond You signature, the technology is being applied in clinical studies to monitor inflammation and other alterations related to bad lifestyle habits and stress that occurs in the body under certain circumstances, inducing chronic diseases in many cases. .
"Our commitment to improving people's lives through personalized genetics remains at the core of our mission. By collaborating with healthcare professionals, we believe we can take our technology to the next level and have an even greater impact on the way in which we approach health and well-being", explains the CEO of Beyond You, Dr. Teresa Tarragó.
Beyond You's ultimate goal is to provide healthcare professionals with the necessary tools to deliver more accurate, evidence-based care so they can optimize diagnosis and personalize treatment for their patients.
The data science startup specializing in RNA analysis has already successfully closed two capital increases worth more than 2 million euros from public and private funds. Kunsen VC, Top 5 partners, mVenturesBCN, Decelera Ventures I FCR, WA4STEAM, NEXT GEN VENTURE A I, SCP and NEXT GEN VENTURE C I, SCP and more than a hundred Business Angels through the Capital Cell platform have participated in the operations.
In addition, national and European public entities such as Next Generation EU, the Center for Technological and Industrial Development (CDTI), Enisa, Retos and Acció have also participated.
Now, Beyond You announces that it is preparing a new round of funding with the aim of obtaining CE certification for its innovative transcriptomics test. This initiative will allow Beyond You to expand its reach and offer its cutting-edge technology to a greater number of healthcare facilities and markets, reinforcing its commitment to providing quality genetic solutions backed by rigorous regulatory standards.
